Resverlogix Corp T.RVX

Alternate Symbol(s): RVXCF

Healthcare Biotechnology

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.

TSX:RVX - Post by User

Resverlogix Corp

Bullboard Posts

Comment by toinv261on May 02, 2015 10:10am

132 Views

Post# 23687960

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:INTERESTING INFO FROM F6 ON THE OTHER BOARD/ THANKS F6

GV, that is great to hear! Nothing like percussion.

I played a Fender Telecaster. It was a wonderful guitar and unfortunately I couldn't do it justice. It was a fantastic instrument and I wish I still had it! I was told by an owner of a musical instrument shop that the Telecaster would be worth about $20,000 today.

Perhaps with the RVX shares I'll be able to buy it back!!!
Cheers
Toinv :)

Bullboard Posts

Pro Women’s Hockey League comes to NHL 25 in December